HMB Supplementation for Soft Tissue Trauma Recovery

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for recovering from soft tissue trauma, including injuries from Botulinum toxin administration, are prolonged and costly, leading to delayed return to regular activity and potential long-term weakness.

Innovation Solution

A composition comprising β-hydroxy-β-methylbutyrate (HMB) is administered to enhance recovery from soft tissue trauma, reduce recovery time, and improve muscle strength and healing, including in muscles affected by Botulinum toxin injections.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional recovery methods (exercise and physical therapy) are used for soft tissue trauma, then muscle strength and tissue integrity are restored, but recovery time is prolonged (six months or more) and treatment costs are high

Engineering Contradiction:

Improvesoft tissue healing qualityVSAvoidrecovery time

Core Design Contradiction:

ReliabilityVSLoss of time

Solution Approach 1:

HMB supplementation is administered before and during the early stages of soft tissue trauma recovery to proactively prevent muscle breakdown and support tissue repair processes, rather than waiting for the injury to heal naturally over six months or more

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The patent changes the biochemical parameter profile of the recovering tissue by introducing HMB, which alters the metabolic state of muscle tissue to reduce proteolysis and promote anabolic processes, thereby accelerating recovery without compromising healing quality

Inventive Principle:

Principle #35Parameter changes

2Object-generated harmful factors

If Botulinum toxin is injected to treat neuromuscular disorders, then muscle spasticity and hyperexcitability are reduced, but muscle strength and contractile material are lost in both injected and non-injected muscles

Engineering Contradiction:

Improvemuscle spasticity and hyperexcitabilityVSAvoidmuscle strength and contractile material

Core Design Contradiction:

Object-generated harmful factorsVSStrength

Solution Approach 1:

HMB supplementation is administered concurrently with Botulinum toxin treatment to counteract the muscle-weakening effects before they fully manifest, creating a protective effect that maintains muscle strength despite the presence of the neurotoxin

Inventive Principle:

Principle #9Preliminary anti-action

Solution Approach 2:

The patent converts the harmful muscle breakdown effect of Botulinum toxin into a beneficial outcome by using HMB to stimulate protein synthesis and prevent atrophy, thereby transforming the net effect from muscle loss to muscle preservation or even gain

Inventive Principle:

Principle #22Blessing in disguise (Convert harm into benefit)

Data Source

PatentUS12208073B2Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) for enhancing recovery from soft tissue trauma

Publication Date: 2025.01.28 METABOLIC TECHNOLOGIES LLC

AI summary

The present invention provides a composition comprising HMB. Methods of administering HMB to an animal are also described. HMB is administered to enhance recovery from soft tissue trauma, including both acute and non-acute soft tissue trauma. Enhanced recovery includes reduced recovery time and enhanced soft tissue healing. Soft tissue trauma includes administration of a Botulinum toxin, such as Botox. Administration of HMB in association with administration of a Botulinum toxin increases muscle strength and/or function in muscle, including adjacent and/or contralateral muscles and prevents or lessens loss of contractile material.